nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiotropium—SLC22A5—Dactinomycin—kidney cancer	0.154	0.254	CbGbCtD
Tiotropium—CYP2D6—Temsirolimus—kidney cancer	0.0767	0.126	CbGbCtD
Tiotropium—CYP3A4—Everolimus—kidney cancer	0.0722	0.119	CbGbCtD
Tiotropium—CYP3A4—Temsirolimus—kidney cancer	0.0488	0.0803	CbGbCtD
Tiotropium—CYP2D6—Pazopanib—kidney cancer	0.0403	0.0664	CbGbCtD
Tiotropium—CYP2D6—Erlotinib—kidney cancer	0.0288	0.0474	CbGbCtD
Tiotropium—CYP3A4—Pazopanib—kidney cancer	0.0256	0.0422	CbGbCtD
Tiotropium—CYP2D6—Sorafenib—kidney cancer	0.0234	0.0385	CbGbCtD
Tiotropium—CYP2D6—Vinblastine—kidney cancer	0.0231	0.038	CbGbCtD
Tiotropium—CHRM3—ureter—kidney cancer	0.0191	0.415	CbGeAlD
Tiotropium—CYP3A4—Erlotinib—kidney cancer	0.0183	0.0301	CbGbCtD
Tiotropium—CYP3A4—Paclitaxel—kidney cancer	0.0167	0.0276	CbGbCtD
Tiotropium—CYP3A4—Sorafenib—kidney cancer	0.0149	0.0245	CbGbCtD
Tiotropium—CYP3A4—Vinblastine—kidney cancer	0.0147	0.0242	CbGbCtD
Tiotropium—CYP3A4—Vincristine—kidney cancer	0.0144	0.0238	CbGbCtD
Tiotropium—CYP2D6—Doxorubicin—kidney cancer	0.0142	0.0234	CbGbCtD
Tiotropium—CYP3A4—Sunitinib—kidney cancer	0.012	0.0198	CbGbCtD
Tiotropium—CYP3A4—Doxorubicin—kidney cancer	0.00902	0.0149	CbGbCtD
Tiotropium—SLC22A5—Temsirolimus—Everolimus—kidney cancer	0.00577	1	CbGdCrCtD
Tiotropium—CYP3A4—urine—kidney cancer	0.0034	0.0741	CbGeAlD
Tiotropium—CYP2D6—urine—kidney cancer	0.00335	0.0729	CbGeAlD
Tiotropium—Aclidinium—BCHE—kidney cancer	0.0032	1	CrCbGaD
Tiotropium—SLC22A4—nephron tubule—kidney cancer	0.00211	0.0459	CbGeAlD
Tiotropium—SLC22A4—renal system—kidney cancer	0.00192	0.0418	CbGeAlD
Tiotropium—SLC22A4—kidney—kidney cancer	0.00185	0.0404	CbGeAlD
Tiotropium—SLC22A4—cortex of kidney—kidney cancer	0.00181	0.0393	CbGeAlD
Tiotropium—CHRM3—renal system—kidney cancer	0.00151	0.033	CbGeAlD
Tiotropium—CHRM3—kidney—kidney cancer	0.00146	0.0319	CbGeAlD
Tiotropium—SLC22A5—nephron tubule—kidney cancer	0.0014	0.0304	CbGeAlD
Tiotropium—SLC22A5—renal system—kidney cancer	0.00127	0.0276	CbGeAlD
Tiotropium—SLC22A5—kidney—kidney cancer	0.00123	0.0267	CbGeAlD
Tiotropium—SLC22A5—cortex of kidney—kidney cancer	0.00119	0.026	CbGeAlD
Tiotropium—SLC22A5—cardiac atrium—kidney cancer	0.00114	0.0247	CbGeAlD
Tiotropium—CYP3A4—renal system—kidney cancer	0.000832	0.0181	CbGeAlD
Tiotropium—CYP2D6—renal system—kidney cancer	0.000819	0.0178	CbGeAlD
Tiotropium—CYP3A4—kidney—kidney cancer	0.000805	0.0175	CbGeAlD
Tiotropium—CYP2D6—kidney—kidney cancer	0.000792	0.0172	CbGeAlD
Tiotropium—Constipation—Sorafenib—kidney cancer	0.000317	0.00095	CcSEcCtD
Tiotropium—Hypersensitivity—Vinblastine—kidney cancer	0.000316	0.000946	CcSEcCtD
Tiotropium—Eye disorder—Paclitaxel—kidney cancer	0.000316	0.000944	CcSEcCtD
Tiotropium—Myalgia—Vincristine—kidney cancer	0.000315	0.000943	CcSEcCtD
Tiotropium—Hypersensitivity—Everolimus—kidney cancer	0.000315	0.000943	CcSEcCtD
Tiotropium—Dyspepsia—Sunitinib—kidney cancer	0.000314	0.000941	CcSEcCtD
Tiotropium—Hyperglycaemia—Capecitabine—kidney cancer	0.000312	0.000935	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000308	0.000923	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000308	0.000922	CcSEcCtD
Tiotropium—Cough—Gemcitabine—kidney cancer	0.000306	0.000917	CcSEcCtD
Tiotropium—Angiopathy—Paclitaxel—kidney cancer	0.000306	0.000917	CcSEcCtD
Tiotropium—Constipation—Sunitinib—kidney cancer	0.000305	0.000914	CcSEcCtD
Tiotropium—Immune system disorder—Paclitaxel—kidney cancer	0.000305	0.000913	CcSEcCtD
Tiotropium—Mediastinal disorder—Paclitaxel—kidney cancer	0.000304	0.000911	CcSEcCtD
Tiotropium—Gastrointestinal pain—Sorafenib—kidney cancer	0.000304	0.000908	CcSEcCtD
Tiotropium—Renal failure—Capecitabine—kidney cancer	0.000304	0.000908	CcSEcCtD
Tiotropium—Hypertension—Gemcitabine—kidney cancer	0.000303	0.000907	CcSEcCtD
Tiotropium—Pruritus—Everolimus—kidney cancer	0.000303	0.000905	CcSEcCtD
Tiotropium—Oedema—Vincristine—kidney cancer	0.000302	0.000904	CcSEcCtD
Tiotropium—Arrhythmia—Paclitaxel—kidney cancer	0.000302	0.000903	CcSEcCtD
Tiotropium—Stomatitis—Capecitabine—kidney cancer	0.000301	0.0009	CcSEcCtD
Tiotropium—Infection—Vincristine—kidney cancer	0.0003	0.000898	CcSEcCtD
Tiotropium—Urinary tract infection—Capecitabine—kidney cancer	0.0003	0.000898	CcSEcCtD
Tiotropium—Arthralgia—Gemcitabine—kidney cancer	0.000299	0.000895	CcSEcCtD
Tiotropium—Chest pain—Gemcitabine—kidney cancer	0.000299	0.000895	CcSEcCtD
Tiotropium—Myalgia—Gemcitabine—kidney cancer	0.000299	0.000895	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000297	0.000888	CcSEcCtD
Tiotropium—Nervous system disorder—Vincristine—kidney cancer	0.000296	0.000886	CcSEcCtD
Tiotropium—Mental disorder—Paclitaxel—kidney cancer	0.000296	0.000885	CcSEcCtD
Tiotropium—Urticaria—Sorafenib—kidney cancer	0.000295	0.000882	CcSEcCtD
Tiotropium—Malnutrition—Paclitaxel—kidney cancer	0.000294	0.00088	CcSEcCtD
Tiotropium—Abdominal pain—Sorafenib—kidney cancer	0.000293	0.000878	CcSEcCtD
Tiotropium—Gastrointestinal pain—Sunitinib—kidney cancer	0.000292	0.000874	CcSEcCtD
Tiotropium—Pruritus—Erlotinib—kidney cancer	0.000292	0.000873	CcSEcCtD
Tiotropium—Epistaxis—Capecitabine—kidney cancer	0.000291	0.000871	CcSEcCtD
Tiotropium—Oedema—Gemcitabine—kidney cancer	0.000287	0.000858	CcSEcCtD
Tiotropium—Infection—Gemcitabine—kidney cancer	0.000285	0.000852	CcSEcCtD
Tiotropium—Back pain—Paclitaxel—kidney cancer	0.000284	0.000851	CcSEcCtD
Tiotropium—Dizziness—Vinblastine—kidney cancer	0.000284	0.000849	CcSEcCtD
Tiotropium—Dizziness—Everolimus—kidney cancer	0.000283	0.000846	CcSEcCtD
Tiotropium—Abdominal pain—Sunitinib—kidney cancer	0.000282	0.000845	CcSEcCtD
Tiotropium—Nervous system disorder—Gemcitabine—kidney cancer	0.000281	0.000841	CcSEcCtD
Tiotropium—Skin disorder—Gemcitabine—kidney cancer	0.000278	0.000833	CcSEcCtD
Tiotropium—Rhinitis—Capecitabine—kidney cancer	0.000278	0.000831	CcSEcCtD
Tiotropium—Vision blurred—Paclitaxel—kidney cancer	0.000277	0.000829	CcSEcCtD
Tiotropium—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000277	0.000827	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000275	0.000824	CcSEcCtD
Tiotropium—Pharyngitis—Capecitabine—kidney cancer	0.000275	0.000823	CcSEcCtD
Tiotropium—Urinary tract disorder—Capecitabine—kidney cancer	0.000274	0.000819	CcSEcCtD
Tiotropium—Hypersensitivity—Sorafenib—kidney cancer	0.000274	0.000818	CcSEcCtD
Tiotropium—Insomnia—Vincristine—kidney cancer	0.000273	0.000818	CcSEcCtD
Tiotropium—Oedema peripheral—Capecitabine—kidney cancer	0.000273	0.000817	CcSEcCtD
Tiotropium—Vomiting—Vinblastine—kidney cancer	0.000273	0.000817	CcSEcCtD
Tiotropium—Dizziness—Erlotinib—kidney cancer	0.000273	0.000816	CcSEcCtD
Tiotropium—Connective tissue disorder—Capecitabine—kidney cancer	0.000272	0.000815	CcSEcCtD
Tiotropium—Vomiting—Everolimus—kidney cancer	0.000272	0.000814	CcSEcCtD
Tiotropium—Urethral disorder—Capecitabine—kidney cancer	0.000272	0.000813	CcSEcCtD
Tiotropium—Paraesthesia—Vincristine—kidney cancer	0.000271	0.000812	CcSEcCtD
Tiotropium—Rash—Everolimus—kidney cancer	0.00027	0.000807	CcSEcCtD
Tiotropium—Dermatitis—Everolimus—kidney cancer	0.000269	0.000806	CcSEcCtD
Tiotropium—Headache—Vinblastine—kidney cancer	0.000269	0.000805	CcSEcCtD
Tiotropium—Angioedema—Paclitaxel—kidney cancer	0.000269	0.000804	CcSEcCtD
Tiotropium—Headache—Everolimus—kidney cancer	0.000268	0.000802	CcSEcCtD
Tiotropium—Abdominal pain—Dactinomycin—kidney cancer	0.000267	0.0008	CcSEcCtD
Tiotropium—Visual impairment—Capecitabine—kidney cancer	0.000267	0.000799	CcSEcCtD
Tiotropium—Syncope—Paclitaxel—kidney cancer	0.000264	0.000789	CcSEcCtD
Tiotropium—Hypersensitivity—Sunitinib—kidney cancer	0.000263	0.000787	CcSEcCtD
Tiotropium—Pruritus—Sorafenib—kidney cancer	0.000263	0.000786	CcSEcCtD
Tiotropium—Vomiting—Erlotinib—kidney cancer	0.000262	0.000785	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000261	0.000781	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Vincristine—kidney cancer	0.000261	0.00078	CcSEcCtD
Tiotropium—Rash—Erlotinib—kidney cancer	0.00026	0.000778	CcSEcCtD
Tiotropium—Dermatitis—Erlotinib—kidney cancer	0.00026	0.000778	CcSEcCtD
Tiotropium—Palpitations—Paclitaxel—kidney cancer	0.00026	0.000777	CcSEcCtD
Tiotropium—Insomnia—Gemcitabine—kidney cancer	0.000259	0.000776	CcSEcCtD
Tiotropium—Eye disorder—Capecitabine—kidney cancer	0.000259	0.000775	CcSEcCtD
Tiotropium—Headache—Erlotinib—kidney cancer	0.000259	0.000773	CcSEcCtD
Tiotropium—Loss of consciousness—Paclitaxel—kidney cancer	0.000258	0.000773	CcSEcCtD
Tiotropium—Constipation—Vincristine—kidney cancer	0.000258	0.000773	CcSEcCtD
Tiotropium—Pain in extremity—Doxorubicin—kidney cancer	0.000258	0.000773	CcSEcCtD
Tiotropium—Paraesthesia—Gemcitabine—kidney cancer	0.000257	0.00077	CcSEcCtD
Tiotropium—Cough—Paclitaxel—kidney cancer	0.000257	0.000768	CcSEcCtD
Tiotropium—Nausea—Vinblastine—kidney cancer	0.000255	0.000763	CcSEcCtD
Tiotropium—Nausea—Everolimus—kidney cancer	0.000254	0.00076	CcSEcCtD
Tiotropium—Hypertension—Paclitaxel—kidney cancer	0.000254	0.00076	CcSEcCtD
Tiotropium—Pruritus—Sunitinib—kidney cancer	0.000253	0.000756	CcSEcCtD
Tiotropium—Angiopathy—Capecitabine—kidney cancer	0.000251	0.000752	CcSEcCtD
Tiotropium—Immune system disorder—Capecitabine—kidney cancer	0.00025	0.000749	CcSEcCtD
Tiotropium—Myalgia—Paclitaxel—kidney cancer	0.00025	0.000749	CcSEcCtD
Tiotropium—Chest pain—Paclitaxel—kidney cancer	0.00025	0.000749	CcSEcCtD
Tiotropium—Arthralgia—Paclitaxel—kidney cancer	0.00025	0.000749	CcSEcCtD
Tiotropium—Mediastinal disorder—Capecitabine—kidney cancer	0.00025	0.000747	CcSEcCtD
Tiotropium—Hypersensitivity—Dactinomycin—kidney cancer	0.000249	0.000745	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000249	0.000744	CcSEcCtD
Tiotropium—Arrhythmia—Capecitabine—kidney cancer	0.000248	0.000741	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000247	0.00074	CcSEcCtD
Tiotropium—Gastrointestinal pain—Vincristine—kidney cancer	0.000247	0.000739	CcSEcCtD
Tiotropium—Dizziness—Sorafenib—kidney cancer	0.000245	0.000734	CcSEcCtD
Tiotropium—Constipation—Gemcitabine—kidney cancer	0.000245	0.000733	CcSEcCtD
Tiotropium—Nausea—Erlotinib—kidney cancer	0.000245	0.000733	CcSEcCtD
Tiotropium—Dry mouth—Paclitaxel—kidney cancer	0.000245	0.000732	CcSEcCtD
Tiotropium—Mental disorder—Capecitabine—kidney cancer	0.000243	0.000727	CcSEcCtD
Tiotropium—Malnutrition—Capecitabine—kidney cancer	0.000241	0.000722	CcSEcCtD
Tiotropium—Dehydration—Doxorubicin—kidney cancer	0.00024	0.000719	CcSEcCtD
Tiotropium—Oedema—Paclitaxel—kidney cancer	0.00024	0.000718	CcSEcCtD
Tiotropium—Abdominal pain—Vincristine—kidney cancer	0.000239	0.000715	CcSEcCtD
Tiotropium—Infection—Paclitaxel—kidney cancer	0.000238	0.000713	CcSEcCtD
Tiotropium—Dry skin—Doxorubicin—kidney cancer	0.000237	0.000708	CcSEcCtD
Tiotropium—Dizziness—Sunitinib—kidney cancer	0.000236	0.000707	CcSEcCtD
Tiotropium—Shock—Paclitaxel—kidney cancer	0.000236	0.000706	CcSEcCtD
Tiotropium—Vomiting—Sorafenib—kidney cancer	0.000236	0.000706	CcSEcCtD
Tiotropium—Nervous system disorder—Paclitaxel—kidney cancer	0.000235	0.000704	CcSEcCtD
Tiotropium—Tachycardia—Paclitaxel—kidney cancer	0.000234	0.000701	CcSEcCtD
Tiotropium—Rash—Sorafenib—kidney cancer	0.000234	0.0007	CcSEcCtD
Tiotropium—Dermatitis—Sorafenib—kidney cancer	0.000234	0.0007	CcSEcCtD
Tiotropium—Back pain—Capecitabine—kidney cancer	0.000233	0.000698	CcSEcCtD
Tiotropium—Skin disorder—Paclitaxel—kidney cancer	0.000233	0.000697	CcSEcCtD
Tiotropium—Headache—Sorafenib—kidney cancer	0.000233	0.000696	CcSEcCtD
Tiotropium—Vision blurred—Capecitabine—kidney cancer	0.000227	0.00068	CcSEcCtD
Tiotropium—Vomiting—Sunitinib—kidney cancer	0.000227	0.00068	CcSEcCtD
Tiotropium—Rash—Sunitinib—kidney cancer	0.000225	0.000674	CcSEcCtD
Tiotropium—Dermatitis—Sunitinib—kidney cancer	0.000225	0.000673	CcSEcCtD
Tiotropium—Headache—Sunitinib—kidney cancer	0.000224	0.00067	CcSEcCtD
Tiotropium—Dysphagia—Doxorubicin—kidney cancer	0.000223	0.000668	CcSEcCtD
Tiotropium—Hypersensitivity—Vincristine—kidney cancer	0.000223	0.000666	CcSEcCtD
Tiotropium—Nausea—Sorafenib—kidney cancer	0.000221	0.00066	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000219	0.000654	CcSEcCtD
Tiotropium—Angina pectoris—Doxorubicin—kidney cancer	0.000217	0.000651	CcSEcCtD
Tiotropium—Insomnia—Paclitaxel—kidney cancer	0.000217	0.000649	CcSEcCtD
Tiotropium—Syncope—Capecitabine—kidney cancer	0.000216	0.000647	CcSEcCtD
Tiotropium—Paraesthesia—Paclitaxel—kidney cancer	0.000215	0.000645	CcSEcCtD
Tiotropium—Vomiting—Dactinomycin—kidney cancer	0.000215	0.000643	CcSEcCtD
Tiotropium—Palpitations—Capecitabine—kidney cancer	0.000213	0.000638	CcSEcCtD
Tiotropium—Rash—Dactinomycin—kidney cancer	0.000213	0.000638	CcSEcCtD
Tiotropium—Nausea—Sunitinib—kidney cancer	0.000212	0.000635	CcSEcCtD
Tiotropium—Loss of consciousness—Capecitabine—kidney cancer	0.000212	0.000635	CcSEcCtD
Tiotropium—Dyspepsia—Paclitaxel—kidney cancer	0.000211	0.000632	CcSEcCtD
Tiotropium—Cough—Capecitabine—kidney cancer	0.000211	0.00063	CcSEcCtD
Tiotropium—Dysuria—Doxorubicin—kidney cancer	0.000209	0.000625	CcSEcCtD
Tiotropium—Hypertension—Capecitabine—kidney cancer	0.000208	0.000623	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000207	0.000621	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000207	0.00062	CcSEcCtD
Tiotropium—Arthralgia—Capecitabine—kidney cancer	0.000205	0.000615	CcSEcCtD
Tiotropium—Chest pain—Capecitabine—kidney cancer	0.000205	0.000615	CcSEcCtD
Tiotropium—Myalgia—Capecitabine—kidney cancer	0.000205	0.000615	CcSEcCtD
Tiotropium—Constipation—Paclitaxel—kidney cancer	0.000205	0.000614	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000204	0.00061	CcSEcCtD
Tiotropium—Pruritus—Gemcitabine—kidney cancer	0.000203	0.000607	CcSEcCtD
Tiotropium—Hyperglycaemia—Doxorubicin—kidney cancer	0.000201	0.000602	CcSEcCtD
Tiotropium—Dry mouth—Capecitabine—kidney cancer	0.000201	0.000601	CcSEcCtD
Tiotropium—Nausea—Dactinomycin—kidney cancer	0.000201	0.000601	CcSEcCtD
Tiotropium—Dizziness—Vincristine—kidney cancer	0.0002	0.000598	CcSEcCtD
Tiotropium—Oedema—Capecitabine—kidney cancer	0.000197	0.000589	CcSEcCtD
Tiotropium—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000196	0.000587	CcSEcCtD
Tiotropium—Renal failure—Doxorubicin—kidney cancer	0.000196	0.000585	CcSEcCtD
Tiotropium—Infection—Capecitabine—kidney cancer	0.000196	0.000585	CcSEcCtD
Tiotropium—Stomatitis—Doxorubicin—kidney cancer	0.000194	0.00058	CcSEcCtD
Tiotropium—Shock—Capecitabine—kidney cancer	0.000194	0.00058	CcSEcCtD
Tiotropium—Urinary tract infection—Doxorubicin—kidney cancer	0.000193	0.000579	CcSEcCtD
Tiotropium—Nervous system disorder—Capecitabine—kidney cancer	0.000193	0.000578	CcSEcCtD
Tiotropium—Tachycardia—Capecitabine—kidney cancer	0.000192	0.000575	CcSEcCtD
Tiotropium—Vomiting—Vincristine—kidney cancer	0.000192	0.000575	CcSEcCtD
Tiotropium—Skin disorder—Capecitabine—kidney cancer	0.000191	0.000572	CcSEcCtD
Tiotropium—Urticaria—Paclitaxel—kidney cancer	0.000191	0.00057	CcSEcCtD
Tiotropium—Rash—Vincristine—kidney cancer	0.000191	0.00057	CcSEcCtD
Tiotropium—Dermatitis—Vincristine—kidney cancer	0.00019	0.000569	CcSEcCtD
Tiotropium—Abdominal pain—Paclitaxel—kidney cancer	0.00019	0.000568	CcSEcCtD
Tiotropium—Headache—Vincristine—kidney cancer	0.000189	0.000566	CcSEcCtD
Tiotropium—Epistaxis—Doxorubicin—kidney cancer	0.000188	0.000562	CcSEcCtD
Tiotropium—Sinusitis—Doxorubicin—kidney cancer	0.000187	0.000559	CcSEcCtD
Tiotropium—Vomiting—Gemcitabine—kidney cancer	0.000182	0.000545	CcSEcCtD
Tiotropium—Rash—Gemcitabine—kidney cancer	0.000181	0.000541	CcSEcCtD
Tiotropium—Dermatitis—Gemcitabine—kidney cancer	0.000181	0.00054	CcSEcCtD
Tiotropium—Headache—Gemcitabine—kidney cancer	0.00018	0.000537	CcSEcCtD
Tiotropium—Nausea—Vincristine—kidney cancer	0.000179	0.000537	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000179	0.000537	CcSEcCtD
Tiotropium—Rhinitis—Doxorubicin—kidney cancer	0.000179	0.000536	CcSEcCtD
Tiotropium—Insomnia—Capecitabine—kidney cancer	0.000178	0.000533	CcSEcCtD
Tiotropium—Pharyngitis—Doxorubicin—kidney cancer	0.000177	0.000531	CcSEcCtD
Tiotropium—Paraesthesia—Capecitabine—kidney cancer	0.000177	0.000529	CcSEcCtD
Tiotropium—Hypersensitivity—Paclitaxel—kidney cancer	0.000177	0.000529	CcSEcCtD
Tiotropium—Urinary tract disorder—Doxorubicin—kidney cancer	0.000176	0.000528	CcSEcCtD
Tiotropium—Oedema peripheral—Doxorubicin—kidney cancer	0.000176	0.000527	CcSEcCtD
Tiotropium—Connective tissue disorder—Doxorubicin—kidney cancer	0.000176	0.000525	CcSEcCtD
Tiotropium—Urethral disorder—Doxorubicin—kidney cancer	0.000175	0.000524	CcSEcCtD
Tiotropium—Dyspepsia—Capecitabine—kidney cancer	0.000173	0.000519	CcSEcCtD
Tiotropium—Visual impairment—Doxorubicin—kidney cancer	0.000172	0.000515	CcSEcCtD
Tiotropium—Nausea—Gemcitabine—kidney cancer	0.00017	0.000509	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00017	0.000509	CcSEcCtD
Tiotropium—Pruritus—Paclitaxel—kidney cancer	0.00017	0.000508	CcSEcCtD
Tiotropium—Constipation—Capecitabine—kidney cancer	0.000168	0.000504	CcSEcCtD
Tiotropium—Eye disorder—Doxorubicin—kidney cancer	0.000167	0.0005	CcSEcCtD
Tiotropium—Angiopathy—Doxorubicin—kidney cancer	0.000162	0.000485	CcSEcCtD
Tiotropium—Immune system disorder—Doxorubicin—kidney cancer	0.000161	0.000483	CcSEcCtD
Tiotropium—Gastrointestinal pain—Capecitabine—kidney cancer	0.000161	0.000482	CcSEcCtD
Tiotropium—Mediastinal disorder—Doxorubicin—kidney cancer	0.000161	0.000482	CcSEcCtD
Tiotropium—Arrhythmia—Doxorubicin—kidney cancer	0.00016	0.000478	CcSEcCtD
Tiotropium—Dizziness—Paclitaxel—kidney cancer	0.000159	0.000475	CcSEcCtD
Tiotropium—Mental disorder—Doxorubicin—kidney cancer	0.000157	0.000468	CcSEcCtD
Tiotropium—Urticaria—Capecitabine—kidney cancer	0.000156	0.000468	CcSEcCtD
Tiotropium—Abdominal pain—Capecitabine—kidney cancer	0.000156	0.000466	CcSEcCtD
Tiotropium—Malnutrition—Doxorubicin—kidney cancer	0.000156	0.000465	CcSEcCtD
Tiotropium—Vomiting—Paclitaxel—kidney cancer	0.000153	0.000457	CcSEcCtD
Tiotropium—Rash—Paclitaxel—kidney cancer	0.000151	0.000453	CcSEcCtD
Tiotropium—Dermatitis—Paclitaxel—kidney cancer	0.000151	0.000452	CcSEcCtD
Tiotropium—Back pain—Doxorubicin—kidney cancer	0.00015	0.00045	CcSEcCtD
Tiotropium—Headache—Paclitaxel—kidney cancer	0.00015	0.00045	CcSEcCtD
Tiotropium—Vision blurred—Doxorubicin—kidney cancer	0.000147	0.000439	CcSEcCtD
Tiotropium—Hypersensitivity—Capecitabine—kidney cancer	0.000145	0.000434	CcSEcCtD
Tiotropium—Nausea—Paclitaxel—kidney cancer	0.000143	0.000426	CcSEcCtD
Tiotropium—Syncope—Doxorubicin—kidney cancer	0.000139	0.000417	CcSEcCtD
Tiotropium—Pruritus—Capecitabine—kidney cancer	0.000139	0.000417	CcSEcCtD
Tiotropium—Palpitations—Doxorubicin—kidney cancer	0.000137	0.000411	CcSEcCtD
Tiotropium—Loss of consciousness—Doxorubicin—kidney cancer	0.000137	0.000409	CcSEcCtD
Tiotropium—Cough—Doxorubicin—kidney cancer	0.000136	0.000406	CcSEcCtD
Tiotropium—Hypertension—Doxorubicin—kidney cancer	0.000134	0.000402	CcSEcCtD
Tiotropium—Myalgia—Doxorubicin—kidney cancer	0.000132	0.000396	CcSEcCtD
Tiotropium—Chest pain—Doxorubicin—kidney cancer	0.000132	0.000396	CcSEcCtD
Tiotropium—Arthralgia—Doxorubicin—kidney cancer	0.000132	0.000396	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000132	0.000393	CcSEcCtD
Tiotropium—Dizziness—Capecitabine—kidney cancer	0.00013	0.00039	CcSEcCtD
Tiotropium—Dry mouth—Doxorubicin—kidney cancer	0.00013	0.000387	CcSEcCtD
Tiotropium—Oedema—Doxorubicin—kidney cancer	0.000127	0.00038	CcSEcCtD
Tiotropium—Infection—Doxorubicin—kidney cancer	0.000126	0.000377	CcSEcCtD
Tiotropium—Vomiting—Capecitabine—kidney cancer	0.000125	0.000375	CcSEcCtD
Tiotropium—Shock—Doxorubicin—kidney cancer	0.000125	0.000374	CcSEcCtD
Tiotropium—Nervous system disorder—Doxorubicin—kidney cancer	0.000124	0.000372	CcSEcCtD
Tiotropium—Rash—Capecitabine—kidney cancer	0.000124	0.000372	CcSEcCtD
Tiotropium—Dermatitis—Capecitabine—kidney cancer	0.000124	0.000371	CcSEcCtD
Tiotropium—Tachycardia—Doxorubicin—kidney cancer	0.000124	0.000371	CcSEcCtD
Tiotropium—Headache—Capecitabine—kidney cancer	0.000123	0.000369	CcSEcCtD
Tiotropium—Skin disorder—Doxorubicin—kidney cancer	0.000123	0.000369	CcSEcCtD
Tiotropium—Nausea—Capecitabine—kidney cancer	0.000117	0.00035	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000116	0.000346	CcSEcCtD
Tiotropium—Insomnia—Doxorubicin—kidney cancer	0.000115	0.000344	CcSEcCtD
Tiotropium—Paraesthesia—Doxorubicin—kidney cancer	0.000114	0.000341	CcSEcCtD
Tiotropium—Dyspepsia—Doxorubicin—kidney cancer	0.000112	0.000334	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.00011	0.000328	CcSEcCtD
Tiotropium—Constipation—Doxorubicin—kidney cancer	0.000109	0.000325	CcSEcCtD
Tiotropium—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000104	0.000311	CcSEcCtD
Tiotropium—Urticaria—Doxorubicin—kidney cancer	0.000101	0.000302	CcSEcCtD
Tiotropium—Abdominal pain—Doxorubicin—kidney cancer	0.0001	0.0003	CcSEcCtD
Tiotropium—Hypersensitivity—Doxorubicin—kidney cancer	9.35e-05	0.00028	CcSEcCtD
Tiotropium—Pruritus—Doxorubicin—kidney cancer	8.98e-05	0.000269	CcSEcCtD
Tiotropium—Dizziness—Doxorubicin—kidney cancer	8.39e-05	0.000251	CcSEcCtD
Tiotropium—Vomiting—Doxorubicin—kidney cancer	8.07e-05	0.000241	CcSEcCtD
Tiotropium—Rash—Doxorubicin—kidney cancer	8e-05	0.000239	CcSEcCtD
Tiotropium—Dermatitis—Doxorubicin—kidney cancer	8e-05	0.000239	CcSEcCtD
Tiotropium—Headache—Doxorubicin—kidney cancer	7.95e-05	0.000238	CcSEcCtD
Tiotropium—Nausea—Doxorubicin—kidney cancer	7.54e-05	0.000226	CcSEcCtD
Tiotropium—CHRM1—Signaling Pathways—GRB7—kidney cancer	2.39e-06	0.000651	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—GRB7—kidney cancer	2.39e-06	0.000648	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—JUNB—kidney cancer	2.38e-06	0.000646	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PAK1—kidney cancer	2.38e-06	0.000646	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—GRB7—kidney cancer	2.36e-06	0.000642	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PGK1—kidney cancer	2.36e-06	0.000641	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—SLC5A3—kidney cancer	2.36e-06	0.000641	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CCBL1—kidney cancer	2.35e-06	0.000638	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—LDHB—kidney cancer	2.31e-06	0.000629	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—SCARB1—kidney cancer	2.29e-06	0.000622	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PTGS1—kidney cancer	2.27e-06	0.000616	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ITPR2—kidney cancer	2.22e-06	0.000605	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PSMD7—kidney cancer	2.22e-06	0.000604	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ITPR2—kidney cancer	2.22e-06	0.000603	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ITPR2—kidney cancer	2.2e-06	0.000597	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—POMC—kidney cancer	2.2e-06	0.000597	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—BCHE—kidney cancer	2.11e-06	0.000573	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—SLC5A5—kidney cancer	2.08e-06	0.000566	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.04e-06	0.000553	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PPAT—kidney cancer	2.04e-06	0.000553	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CTNNA1—kidney cancer	2.02e-06	0.000548	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CTNNA1—kidney cancer	2.01e-06	0.000547	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—SLC2A1—kidney cancer	2.01e-06	0.000546	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CA9—kidney cancer	2.01e-06	0.000545	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—HSPB1—kidney cancer	2.01e-06	0.000545	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—EIF4EBP1—kidney cancer	2.01e-06	0.000545	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—HSPB1—kidney cancer	2e-06	0.000543	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—EIF4EBP1—kidney cancer	2e-06	0.000543	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CTNNA1—kidney cancer	1.99e-06	0.000541	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—EIF4EBP1—kidney cancer	1.98e-06	0.000538	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—HSPB1—kidney cancer	1.98e-06	0.000538	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IGF2—kidney cancer	1.94e-06	0.000528	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CDKN2B—kidney cancer	1.93e-06	0.000526	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—FH—kidney cancer	1.89e-06	0.000514	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—APRT—kidney cancer	1.89e-06	0.000514	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IGF1R—kidney cancer	1.88e-06	0.000511	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PSMD7—kidney cancer	1.86e-06	0.000507	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ANXA1—kidney cancer	1.86e-06	0.000507	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TSC1—kidney cancer	1.86e-06	0.000507	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TSC1—kidney cancer	1.86e-06	0.000505	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ANXA1—kidney cancer	1.86e-06	0.000505	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PSMD7—kidney cancer	1.86e-06	0.000505	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PSMD7—kidney cancer	1.84e-06	0.0005	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ANXA1—kidney cancer	1.84e-06	0.0005	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TSC1—kidney cancer	1.84e-06	0.0005	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—RAF1—kidney cancer	1.81e-06	0.000492	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—FLT1—kidney cancer	1.81e-06	0.000491	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—FLT1—kidney cancer	1.8e-06	0.000489	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—IL2—kidney cancer	1.79e-06	0.000486	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—FLT1—kidney cancer	1.78e-06	0.000485	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GPC3—kidney cancer	1.78e-06	0.000484	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CA2—kidney cancer	1.73e-06	0.00047	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CRABP1—kidney cancer	1.71e-06	0.000464	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—POMC—kidney cancer	1.7e-06	0.000463	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—POMC—kidney cancer	1.7e-06	0.000461	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ALAD—kidney cancer	1.69e-06	0.000458	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—POMC—kidney cancer	1.68e-06	0.000457	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—GSTP1—kidney cancer	1.68e-06	0.000456	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PAK1—kidney cancer	1.67e-06	0.000455	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—JUNB—kidney cancer	1.67e-06	0.000455	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PAK1—kidney cancer	1.67e-06	0.000454	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—JUNB—kidney cancer	1.67e-06	0.000454	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PAK1—kidney cancer	1.65e-06	0.000449	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—JUNB—kidney cancer	1.65e-06	0.000449	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.65e-06	0.000447	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—IL2—kidney cancer	1.62e-06	0.000441	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.61e-06	0.000437	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—ABCB1—kidney cancer	1.59e-06	0.000431	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ITPR2—kidney cancer	1.59e-06	0.000431	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—HIF1A—kidney cancer	1.55e-06	0.000421	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—POMC—kidney cancer	1.55e-06	0.00042	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TSC2—kidney cancer	1.54e-06	0.000419	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.54e-06	0.000419	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PGK1—kidney cancer	1.54e-06	0.000419	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—POMC—kidney cancer	1.54e-06	0.000419	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—GSTM1—kidney cancer	1.54e-06	0.000419	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—POMC—kidney cancer	1.53e-06	0.000415	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—LDHB—kidney cancer	1.51e-06	0.000411	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—KDR—kidney cancer	1.48e-06	0.000402	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CYP1A1—kidney cancer	1.46e-06	0.000397	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ACHE—kidney cancer	1.45e-06	0.000393	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GSTT1—kidney cancer	1.45e-06	0.000393	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—SCARB1—kidney cancer	1.37e-06	0.000372	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IGF2—kidney cancer	1.37e-06	0.000372	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IGF2—kidney cancer	1.36e-06	0.000371	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—APC—kidney cancer	1.36e-06	0.00037	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—KIT—kidney cancer	1.36e-06	0.00037	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CDKN2B—kidney cancer	1.36e-06	0.00037	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CDKN2B—kidney cancer	1.36e-06	0.000369	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PTGS1—kidney cancer	1.35e-06	0.000368	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IGF2—kidney cancer	1.35e-06	0.000367	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CDKN2B—kidney cancer	1.34e-06	0.000366	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PSMD7—kidney cancer	1.33e-06	0.000361	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IGF1R—kidney cancer	1.32e-06	0.00036	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IGF1R—kidney cancer	1.32e-06	0.000359	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CA9—kidney cancer	1.31e-06	0.000357	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IGF1R—kidney cancer	1.31e-06	0.000355	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—MAPK3—kidney cancer	1.3e-06	0.000355	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—POMC—kidney cancer	1.3e-06	0.000353	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—BRAF—kidney cancer	1.28e-06	0.000348	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—RAF1—kidney cancer	1.27e-06	0.000347	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—RAF1—kidney cancer	1.27e-06	0.000345	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—BCHE—kidney cancer	1.26e-06	0.000342	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—IL2—kidney cancer	1.26e-06	0.000342	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—RAF1—kidney cancer	1.26e-06	0.000342	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—IL2—kidney cancer	1.25e-06	0.000341	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.24e-06	0.000338	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—IL2—kidney cancer	1.24e-06	0.000338	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—MAPK1—kidney cancer	1.24e-06	0.000338	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.2e-06	0.000327	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—PIK3CA—kidney cancer	1.19e-06	0.000323	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—KRAS—kidney cancer	1.17e-06	0.000319	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—IL2—kidney cancer	1.14e-06	0.000311	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—IL2—kidney cancer	1.14e-06	0.00031	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—IL2—kidney cancer	1.13e-06	0.000307	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CRABP1—kidney cancer	1.12e-06	0.000303	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—HIF1A—kidney cancer	1.09e-06	0.000296	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—POMC—kidney cancer	1.09e-06	0.000296	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TSC2—kidney cancer	1.09e-06	0.000295	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—HIF1A—kidney cancer	1.09e-06	0.000295	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TSC2—kidney cancer	1.08e-06	0.000294	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—PIK3CA—kidney cancer	1.08e-06	0.000293	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—HIF1A—kidney cancer	1.08e-06	0.000292	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TSC2—kidney cancer	1.07e-06	0.000292	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—RAF1—kidney cancer	1.07e-06	0.000291	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—RELA—kidney cancer	1.06e-06	0.000289	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—ERBB2—kidney cancer	1.06e-06	0.000288	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MTOR—kidney cancer	1.04e-06	0.000284	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—KDR—kidney cancer	1.04e-06	0.000283	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—KDR—kidney cancer	1.04e-06	0.000282	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ITPR2—kidney cancer	1.04e-06	0.000282	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—KDR—kidney cancer	1.03e-06	0.00028	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GSTP1—kidney cancer	1e-06	0.000272	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CDKN1B—kidney cancer	9.8e-07	0.000266	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—KIT—kidney cancer	9.59e-07	0.000261	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—APC—kidney cancer	9.59e-07	0.000261	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IL2—kidney cancer	9.59e-07	0.000261	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—APC—kidney cancer	9.56e-07	0.00026	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—KIT—kidney cancer	9.56e-07	0.00026	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ABCB1—kidney cancer	9.49e-07	0.000258	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—APC—kidney cancer	9.47e-07	0.000257	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—KIT—kidney cancer	9.47e-07	0.000257	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ACHE—kidney cancer	9.45e-07	0.000257	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GSTT1—kidney cancer	9.45e-07	0.000257	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CCND1—kidney cancer	9.35e-07	0.000254	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—JUN—kidney cancer	9.33e-07	0.000254	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CTNNB1—kidney cancer	9.26e-07	0.000252	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GSTM1—kidney cancer	9.21e-07	0.00025	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—MAPK3—kidney cancer	9.19e-07	0.00025	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—MAPK3—kidney cancer	9.16e-07	0.000249	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—POMC—kidney cancer	9.13e-07	0.000248	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—POMC—kidney cancer	9.1e-07	0.000248	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—MAPK3—kidney cancer	9.07e-07	0.000247	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PTEN—kidney cancer	9.02e-07	0.000245	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—BRAF—kidney cancer	9.02e-07	0.000245	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—POMC—kidney cancer	9.02e-07	0.000245	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—BRAF—kidney cancer	8.99e-07	0.000244	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SCARB1—kidney cancer	8.95e-07	0.000243	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—BRAF—kidney cancer	8.9e-07	0.000242	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PTGS1—kidney cancer	8.86e-07	0.000241	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—MAPK1—kidney cancer	8.74e-07	0.000238	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CYP1A1—kidney cancer	8.73e-07	0.000237	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—MAPK1—kidney cancer	8.71e-07	0.000237	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PSMD7—kidney cancer	8.69e-07	0.000236	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PTGS2—kidney cancer	8.68e-07	0.000236	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—MAPK1—kidney cancer	8.63e-07	0.000235	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—PIK3CA—kidney cancer	8.35e-07	0.000227	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—PIK3CA—kidney cancer	8.33e-07	0.000226	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—KRAS—kidney cancer	8.26e-07	0.000225	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—PIK3CA—kidney cancer	8.25e-07	0.000224	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—BCHE—kidney cancer	8.24e-07	0.000224	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—KRAS—kidney cancer	8.23e-07	0.000224	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—KRAS—kidney cancer	8.15e-07	0.000222	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—VEGFA—kidney cancer	8.15e-07	0.000222	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SLC5A5—kidney cancer	8.13e-07	0.000221	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SLC2A1—kidney cancer	7.86e-07	0.000214	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MAPK3—kidney cancer	7.71e-07	0.00021	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—PIK3CA—kidney cancer	7.59e-07	0.000206	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PTEN—kidney cancer	7.57e-07	0.000206	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—PIK3CA—kidney cancer	7.56e-07	0.000206	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—RAF1—kidney cancer	7.53e-07	0.000205	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—RAF1—kidney cancer	7.51e-07	0.000204	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MYC—kidney cancer	7.5e-07	0.000204	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—RELA—kidney cancer	7.5e-07	0.000204	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	7.49e-07	0.000204	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—RELA—kidney cancer	7.47e-07	0.000203	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ERBB2—kidney cancer	7.45e-07	0.000203	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—RAF1—kidney cancer	7.43e-07	0.000202	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ERBB2—kidney cancer	7.43e-07	0.000202	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—RELA—kidney cancer	7.4e-07	0.000201	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ERBB2—kidney cancer	7.35e-07	0.0002	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MTOR—kidney cancer	7.35e-07	0.0002	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MAPK1—kidney cancer	7.34e-07	0.000199	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MTOR—kidney cancer	7.33e-07	0.000199	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MTOR—kidney cancer	7.26e-07	0.000197	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—KRAS—kidney cancer	6.93e-07	0.000188	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CDKN1B—kidney cancer	6.9e-07	0.000188	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CDKN1B—kidney cancer	6.88e-07	0.000187	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	6.81e-07	0.000185	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IL2—kidney cancer	6.75e-07	0.000184	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IL2—kidney cancer	6.73e-07	0.000183	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IL2—kidney cancer	6.66e-07	0.000181	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CCND1—kidney cancer	6.58e-07	0.000179	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—JUN—kidney cancer	6.57e-07	0.000179	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CCND1—kidney cancer	6.56e-07	0.000178	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GSTP1—kidney cancer	6.55e-07	0.000178	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—JUN—kidney cancer	6.55e-07	0.000178	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CTNNB1—kidney cancer	6.52e-07	0.000177	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—POMC—kidney cancer	6.51e-07	0.000177	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CCND1—kidney cancer	6.5e-07	0.000177	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CTNNB1—kidney cancer	6.5e-07	0.000177	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—JUN—kidney cancer	6.48e-07	0.000176	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	6.43e-07	0.000175	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PIK3CA—kidney cancer	6.36e-07	0.000173	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PTEN—kidney cancer	6.35e-07	0.000173	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PTEN—kidney cancer	6.33e-07	0.000172	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PTEN—kidney cancer	6.27e-07	0.00017	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ABCB1—kidney cancer	6.2e-07	0.000169	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TP53—kidney cancer	6.16e-07	0.000167	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GSTM1—kidney cancer	6.02e-07	0.000164	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—VEGFA—kidney cancer	5.74e-07	0.000156	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—VEGFA—kidney cancer	5.72e-07	0.000156	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP1A1—kidney cancer	5.71e-07	0.000155	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—VEGFA—kidney cancer	5.66e-07	0.000154	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MAPK3—kidney cancer	5.43e-07	0.000148	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MAPK3—kidney cancer	5.41e-07	0.000147	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MAPK3—kidney cancer	5.36e-07	0.000146	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PIK3CA—kidney cancer	5.34e-07	0.000145	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MYC—kidney cancer	5.28e-07	0.000144	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MYC—kidney cancer	5.26e-07	0.000143	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MYC—kidney cancer	5.21e-07	0.000142	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PTGS2—kidney cancer	5.19e-07	0.000141	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MAPK1—kidney cancer	5.16e-07	0.00014	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MAPK1—kidney cancer	5.15e-07	0.00014	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MAPK1—kidney cancer	5.1e-07	0.000139	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—KRAS—kidney cancer	4.88e-07	0.000133	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—KRAS—kidney cancer	4.86e-07	0.000132	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—KRAS—kidney cancer	4.82e-07	0.000131	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PTEN—kidney cancer	4.53e-07	0.000123	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PIK3CA—kidney cancer	4.48e-07	0.000122	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PIK3CA—kidney cancer	4.47e-07	0.000121	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	4.42e-07	0.00012	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TP53—kidney cancer	4.34e-07	0.000118	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TP53—kidney cancer	4.32e-07	0.000117	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TP53—kidney cancer	4.28e-07	0.000116	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—POMC—kidney cancer	4.26e-07	0.000116	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PTGS2—kidney cancer	3.39e-07	9.23e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PIK3CA—kidney cancer	3.19e-07	8.68e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PTEN—kidney cancer	2.96e-07	8.05e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.09e-07	5.68e-05	CbGpPWpGaD
